Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New sperm test could predict IVF success

NCT ID NCT05966883

Diagnosis Sponsor: Inherent Biosciences Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing a new sperm quality test called SpermQT. It aims to see if the test can predict how likely a couple is to get pregnant with treatments like IUI or IVF. About 1,000 couples will take part, and researchers will track pregnancy outcomes based on the test results.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 1,000 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jan 2023

Expected to finish

Sep 2026

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Couples that are eligible for an IUI procedure and/or have been recommended to pursue IUI, and/or couples have recently completed an IUI cycle (no matter the outcome)

Ages

18 to 45 years

Sex

Anyone

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * The subjects have been recommended to pursue IUI, or they have recently completed an IUI (regardless of outcome) * Male partner is under 45 years of age * Female partner is under 38 years of age * The total motile sperm count from the raw semen analysis must be greater than or equal to 10 million Exclusion Criteria: * The female or male partner have a BMI equal to or greater than 40 * The male partner has undergone male testosterone replacement therapy in the last 6 months * Either the female or male partner have a history of recurrent pregnancy loss, defined as 2 or more consecutive clinical/ultrasound pregnancy losses * There are any known factors contributing to female factor infertility, such as but not limited to: * Severe Endometriosis (stage 3 or higher, endometrioma on ovaries) * Multiple uterine fibroids 5cm or larger * Severe Asherman's Syndrome * Severe Mullerian anomaly * Lack of tubal patency in at least one fallopian tubes

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Male infertility are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

male infertility

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Male infertility

Contacts and locations

Locations

  • Boston IVF

    Waltham, Massachusetts, 02451, United States

  • Inception Fertility, LLC

    Houston, Texas, 77081, United States

  • Male Fertility and Sexual Medicine Specialists

    San Diego, California, 92120, United States

  • Shady Grove Fertility

    Greenwood Village, Colorado, 80111, United States

  • University of Washington

    Seattle, Washington, 98105, United States

  • Yale Medicine

    Orange, Connecticut, 06477, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.